Dutch health technology giant Royal Philips has received FDA 510 (k) approval for its IntelliVue MX750 and MX850 patient monitors.
The monitors, which received FDA emergency approval in 2020 and CE marked in Europe in 2019, are designed to aid clinical decisions, manage a patient’s condition and needs, and improve infection control in the hospital setting.
WHY IT IS IMPORTANT
Philips is showcasing the MX750 and MX850 as its most advanced monitors, including integration with other Philips technologies and offering vendors the ability to customize the monitors to suit their care environment, even in a virtual room.
The company is also promoting the ability to feed data into Philips’ acute care telemedicine solution and into a hospital’s EHR.
“Continuous patient monitoring plays a critical role in overall patient safety while providing doctors and nurses with the holistic view they need to best support their patients and manage their workload,” said Sandralesenfants, General Manager of Hospital Patient Monitoring at Philips, in a statement.
“Philips IntelliVue MX750 and MX850 patient monitors are our most advanced patient monitors and an integral part of our modular portfolio of hardware, software, services and consumables that can be tailored to provide integrated monitoring solutions that meet the unique needs of every healthcare provider.”
THE BIGGER TREND
This isn’t Philips’ only FDA approval this year. It scored last month another 510 (k) for its liver fat quantitation tool that helps clinicians diagnose early-stage fatty liver.
The company also announced plans to acquire Cardiologs recently received its own FDA approval to use its AI-powered cardiac diagnostic platform in children and adolescents.
In October, Philips launched a new digital pathology platform called IntelliSite and announced two new tools in its HealthSuite this summer: a patient flow tool and its acute telemedicine product.
“When we think about the key issues we’re supporting and we want to double it, then one of the needs for collaboration on care has really increased,” said Roy Jakobs, chief business leader for connected care at Philips MobiHealthNews at the time of HealthSuite’s announcement.
“And COVID of course accelerated the need for this in unprecedented ways where it exposed the system in terms of lack of collaboration.[and]what effects this had, both in terms of the effects on the patient and the effects on resource management. “